Professor of Ophthalmology at University of Paris and Head of the department of Ophthalmology at Lariboisière University Hospital (Paris, France). He has authored more than 140 medical and scientific articles and has made numerous contributions to ophthalmology textbooks. Dr. Tadayoni completed undergraduate training in medicine at the University of Marseille, and his M.D. and internship at Paris V University. He completed his studies with a retina fellowship at Lariboisière University Hospital. Simultaneously, he pursued his Ph.D. in Science at Paris VII University and the Paris Vision Institute.
Christophe Baudouin is professor of Ophthalmology since 1995. He is chairman of the department of Ophthalmology III in Quinze-Vingts National Ophthalmology Hospital, Paris, president of the Medical Council since 2016. Since 2008 he is also the Director of an INSERM-labelled research group, located in Vision Institute, Sorbonne University, a research center dedicated to ophthalmology. He is currently the president of the European Dry Eye Society, Editor-in-chief of the French Journal of Ophthalmology, vice-president of the French Glaucoma Society, and active member of several international societies, including the prestigious American Ophthalmological Society and Academia Ophthalmologica Internationalis, as well as member of the board of the International Council of Ophthalmology (ICO).
Managing Partner of Retinal Consultants of Arizona, Founding Member of the Spectra Eye Institute and Clinical Professor at the Department of Ophthalmology at the Keck School of Medicine, University of Southern California. Globally recognized as a clinical researcher, having served as Principal Investigator for over 100 multicenter clinical trials for emerging and FDA-approved therapies for wet age-related macular degeneration including Beovu®, Lucentis® and Eylea®. Dr. Dugel has authored more than 200 papers and 35 book chapters. He is on the Editorial Board of several major medical journals.
Dr. Stefánsson is a leading physician in the field of diabetic eye disease and diabetic eye screening. Dr. Stefánsson has co-founded four biotechnology firms in addition to Oculis, including Cyclops ehf. which was acquired by DeCode Genetics in 2000. He contributes to a number of ophthalmological publications either as chief editor or on the editorial board. Dr. Stefánsson was knighted by the President of Iceland in 2007 and received a number of awards in science and ophthalmology, such as Iceland’s highest award in science in 2008 and the gold medal of the European Academy of Ophthalmology in 2014 among many other honours. Dr. Stefánsson has published more than 300 peer-reviewed international publications, more than 400 abstracts, numerous book chapters and patents. Dr. Stefánsson received a degree in medicine from the University of Iceland Medical School and a Ph.D. in physiology from Duke University followed by a residency and faculty position at Duke. He has served as Vice Dean and Dean of the Faculty of Medicine at the University of Iceland and served as Professor and Chair of the Department of Ophthalmology at the National University Hospital in Iceland since 1993.